
    
      Eligible subjects will check into the unit on Day-2 and remain confined to the clinical unit
      until Day 17.

      Cohorts 2 and 3, which may run in parallel, will only be enrolled after review of the
      available safety data of Cohort 1 by the Safety Review Team.
    
  